Federal agencies count all fatalities prevented by regulation as having the same value for the purposes of cost-benefit analysis, making no adjustment for the age of the person saved. This uniform valuation is guided by empirical studies that find that the young are not willing to pay more than the elderly for small risk reductions in private markets.
"The Young, the Old, and the Economists: Rethinking How Agencies Account for Age in Cost-Benefit Analysis,"
Yale Journal of Health Policy, Law, and Ethics:
2, Article 3.
Available at: http://digitalcommons.law.yale.edu/yjhple/vol14/iss2/3